Harmless and remarkably successful vaccines are available for two viral STIs: hepatitis B and HPV. These vaccines have represented key developments in STI avoidance. By the end of 2023, the HPV vaccine had been launched as Component of plan immunization programmes in 140countries, mostly higher- and